Saligo, Francisco S.
HRN: 15-92-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/26/2023
03/05/2023
IVTT
1.5 Grams
Q6hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes